472 related articles for article (PubMed ID: 19839966)
41. Bupropion for the treatment of methamphetamine dependence.
Elkashef AM; Rawson RA; Anderson AL; Li SH; Holmes T; Smith EV; Chiang N; Kahn R; Vocci F; Ling W; Pearce VJ; McCann M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D
Neuropsychopharmacology; 2008 Apr; 33(5):1162-70. PubMed ID: 17581531
[TBL] [Abstract][Full Text] [Related]
42. Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia.
Wallace C; Galloway T; McKetin R; Kelly E; Leary J
Drug Alcohol Rev; 2009 Nov; 28(6):592-9. PubMed ID: 19930011
[TBL] [Abstract][Full Text] [Related]
43. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
[TBL] [Abstract][Full Text] [Related]
44. A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis.
Sulaiman AH; Gill JS; Said MA; Zainal NZ; Hussein HM; Guan NC
Int J Psychiatry Clin Pract; 2013 Jun; 17(2):131-8. PubMed ID: 22486597
[TBL] [Abstract][Full Text] [Related]
45. Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial.
Nuijten M; Blanken P; van de Wetering B; Nuijen B; van den Brink W; Hendriks VM
Lancet; 2016 May; 387(10034):2226-34. PubMed ID: 27015909
[TBL] [Abstract][Full Text] [Related]
46. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
[TBL] [Abstract][Full Text] [Related]
47. Hair analysis and self-report of methamphetamine use by methamphetamine dependent individuals.
Han E; Paulus MP; Wittmann M; Chung H; Song JM
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(7-8):541-7. PubMed ID: 21296038
[TBL] [Abstract][Full Text] [Related]
48. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
Rezaei F; Ghaderi E; Mardani R; Hamidi S; Hassanzadeh K
Fundam Clin Pharmacol; 2016 Jun; 30(3):282-9. PubMed ID: 26751259
[TBL] [Abstract][Full Text] [Related]
49. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
[TBL] [Abstract][Full Text] [Related]
50. Effects of repeated hair washing and a single hair dyeing on concentrations of methamphetamine and amphetamine in human hairs.
Baeck S; Han E; Chung H; Pyo M
Forensic Sci Int; 2011 Mar; 206(1-3):77-80. PubMed ID: 20650577
[TBL] [Abstract][Full Text] [Related]
51. Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence.
Shearer J; Wodak A; Mattick RP; Van Beek I; Lewis J; Hall W; Dolan K
Addiction; 2001 Sep; 96(9):1289-96. PubMed ID: 11672493
[TBL] [Abstract][Full Text] [Related]
52. A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome.
Olson LG; Ambrogetti A; Sutherland DC
Psychosomatics; 2003; 44(1):38-43. PubMed ID: 12515836
[TBL] [Abstract][Full Text] [Related]
53. Dexamphetamine improves upper extremity outcome during rehabilitation after stroke: a pilot randomized controlled trial.
Schuster C; Maunz G; Lutz K; Kischka U; Sturzenegger R; Ettlin T
Neurorehabil Neural Repair; 2011 Oct; 25(8):749-55. PubMed ID: 21712481
[TBL] [Abstract][Full Text] [Related]
54. It's the thought that counts: craving metacognitions and their role in abstinence from methamphetamine use.
Lee NK; Pohlman S; Baker A; Ferris J; Kay-Lambkin F
J Subst Abuse Treat; 2010 Apr; 38(3):245-50. PubMed ID: 20116959
[TBL] [Abstract][Full Text] [Related]
55. Treatments for methamphetamine abuse: a literature review for the clinician.
Brackins T; Brahm NC; Kissack JC
J Pharm Pract; 2011 Dec; 24(6):541-50. PubMed ID: 22095579
[TBL] [Abstract][Full Text] [Related]
56. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
Heinzerling KG; Swanson AN; Kim S; Cederblom L; Moe A; Ling W; Shoptaw S
Drug Alcohol Depend; 2010 Jun; 109(1-3):20-9. PubMed ID: 20092966
[TBL] [Abstract][Full Text] [Related]
57. Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence.
Ezard N; Dunlop A; Clifford B; Bruno R; Carr A; Bissaker A; Lintzeris N
BMC Psychiatry; 2016 Dec; 16(1):428. PubMed ID: 27905916
[TBL] [Abstract][Full Text] [Related]
58. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial.
Grabowski J; Rhoades H; Schmitz J; Stotts A; Daruzska LA; Creson D; Moeller FG
J Clin Psychopharmacol; 2001 Oct; 21(5):522-6. PubMed ID: 11593078
[TBL] [Abstract][Full Text] [Related]
59. Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia.
McKetin R; Dunlop AJ; Holland RM; Sutherland RA; Baker AL; Salmon AM; Hudson SL
Drug Alcohol Rev; 2013 Jan; 32(1):80-7. PubMed ID: 22642414
[TBL] [Abstract][Full Text] [Related]
60. Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.
Mooney ME; Herin DV; Schmitz JM; Moukaddam N; Green CE; Grabowski J
Drug Alcohol Depend; 2009 Apr; 101(1-2):34-41. PubMed ID: 19058926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
